Menu
Recruiting NCT07059923

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

— Observational Lung Cancer (Diagnosis)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Lung Cancer (Diagnosis). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.

Primary outcome measures

  • Progression-free survival [Time frame: 1 year]
  • disease-free survival [Time frame: 1 year]
  • overall survival [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Patients were treated for lung cancer in Wuhan Union Hospital from July 2025 to July 2026;
  • Aged > 18 years old;
  • At least one CT scan before treatment;
  • Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion criteria

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignancy other than lung cancer;
  • Unclear pathological diagnosis.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan

Identifiers

NCT: NCT07059923 · 2025-0584

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗